Intrauterine use of hyerconcentrated platelet concentrates collected with Trima Accel(TM) in neonatale alloimmune thrombocytopenia
JWM Engel, TW Goecke, M Schroth, F Faschingbauer, J Ringwald, RL Schild · Geburtshilfe und Frauenheilkunde · 2008 · Heft 09
Bibliografische Angaben
Zusammenfassung
Neonatal alloimmune thrombocytopenia (NAIT) is a clinical syndrome that is characterized by marked thrombocytopenia and antenatal intracranial hemorrhage in the fetus or neonate occurring before or shortly after birth. NAIT is caused by the diaplacental transfer of maternal antibodies against human PLT antigens (HPA) carried by the PLTs of the fetus. Among Caucasian population, the most common antibodies are directed against HPA–1a and HPA–5b. Such maternal antibodies are detectable in approximately 1 in 350 pregnancies. Up to 25% of the cases, however, remain clinically silent. So the birth of a first affected…